Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Bristol-Myers Squibb
(NY:
BMY
)
47.51
+1.22 (+2.64%)
Official Closing Price
Updated: 7:00 PM EDT, Jul 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bristol-Myers Squibb
< Previous
1
2
3
4
5
6
7
8
9
...
75
76
Next >
FDA Expands Surprise Inspections At Foreign Drug And Food Facilities, Targets Double Standards In Overseas Manufacturing Oversight
May 06, 2025
FDA to increase surprise inspections at foreign facilities as U.S. companies pour billions into domestic drug and device manufacturing.
Via
Benzinga
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
May 06, 2025
Via
Benzinga
Bristol Myers Squibb Appoints Cari Gallman as Executive Vice President, General Counsel and Chief Policy Officer
May 06, 2025
From
Bristol Myers Squibb
Via
Business Wire
Earnings Scheduled For April 24, 2025
April 24, 2025
Via
Benzinga
FDA Pushes Potential Approval For Cytokinetics' Experimental Heart Drug By Three Months
May 02, 2025
FDA extended the aficamten decision deadline to Dec. 26 after classifying the REMS submission as a major amendment to the NDA review.
Via
Benzinga
1 Stock Under $50 with Solid Fundamentals and 2 to Keep Off Your Radar
May 02, 2025
Stocks trading between $10 and $50 can be particularly interesting as they frequently represent businesses that have survived their early challenges. However, investors should remain vigilant as some...
Via
StockStory
Bristol-Myers Squibb Co (NYSE:BMY): A High-Yield Dividend Stock Worth Considering
April 30, 2025
Bristol-Myers Squibb Co (NYSE:BMY): A High-Yield Dividend Stock Worth Considering
Via
Chartmill
This High-Yield Pharma Stock Looks Like an Incredible Bargain
April 30, 2025
Via
The Motley Fool
Topics
Intellectual Property
Don’t Be Fooled by the Bounce: The Market Storm Isn’t Over Yet
April 29, 2025
Recent upticks in the market may disguise the ongoing risks that remain for investors; these factors point to the importance of a defensive strategy.
Via
MarketBeat
Topics
Economy
Government
World Trade
Large Cap Biopharmaceutical Update: Mixed Performance As Tariffs Loom
April 28, 2025
Biopharma stocks rally along with many of our SMID cap trades. The market situation with pharmaceuticals is even more complicated because we started off with legislation (the IRA) trying to curb rising...
Via
Talk Markets
Topics
ETFs
Stocks / Equities
Top 3 Health Care Stocks That May Rocket Higher In April
April 28, 2025
Via
Benzinga
Pfizer (PFE) Reports Q1: Everything You Need To Know Ahead Of Earnings
April 28, 2025
Global pharmaceutical company Pfizer (NYSE:PFE) will be reporting earnings tomorrow before market hours. Here’s what you need to know.
Via
StockStory
Topics
Government
World Trade
4 Surefire Dividend Stocks to Buy in the Stock Market Sell-Off
April 26, 2025
Via
The Motley Fool
Topics
Economy
Intellectual Property
World Trade
S&P 500 Rallies 2% On Nvidia, Tesla Gains — But Market Mood Stuck In 'Fear'
April 25, 2025
Via
Benzinga
Topics
Stocks
Gold Gains 1%; Bristol Myers Squibb Posts Upbeat Results
April 24, 2025
Via
Benzinga
Bristol Myers Delivers Upbeat 2025 Forecast Despite China Tariffs Impact
April 24, 2025
Bristol Myers reported Q1 revenue of $11.2 billion, raised 2025 guidance, and saw strong Growth Portfolio sales offset Legacy product declines.
Via
Benzinga
Wall Street Rally Extends Into Third Day: What's Driving Markets Thursday?
April 24, 2025
U.S. equities are pushing higher for a third straight session, eyeing the longest winning streak since the Trump tariff announcement on April 2, as optimism over corporate earnings and easing trade...
Via
Benzinga
Topics
Government
World Trade
Bristol Myers Reports Upbeat Q1 Earnings, Raises Full-Year Guidance: Retail’s Optimistic
April 24, 2025
The company now expects full-year diluted EPS in the range of $6.70 to $7.00, up from its previous guidance of $6.55 to $6.85.
Via
Stocktwits
Topics
World Trade
Bristol Myers Continues A Two-Day Losing Spree Despite Walloping Earnings Estimates
April 24, 2025
The company recently faced two big clinical trial setbacks that have weighed on shares recently.
Via
Investor's Business Daily
Topics
Government
Bristol-Myers Squibb (NYSE:BMY) Reports Upbeat Q1, Full-Year Outlook Slightly Exceeds Expectations
April 24, 2025
Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) reported revenue ahead of Wall Street’s expectations in Q1 CY2025, but sales fell by 5.6% year on year to $11.2 billion. The company’s...
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Bristol Myers Squibb Reports First Quarter Financial Results for 2025
April 24, 2025
From
Bristol Myers Squibb
Via
Business Wire
US Stock Futures Drop Amid Mixed Signals From White House On US-China Trade: 'Focus On Quality In A Diversified Manner,' Says Expert
April 24, 2025
U.S. stock futures fell on Thursday after a two-day advance. Futures of major benchmark indices were lower in premarket.
Via
Benzinga
PepsiCo, Alphabet And 3 Stocks To Watch Heading Into Thursday
April 24, 2025
Via
Benzinga
Dow Jumps Over 400 Points Amid China Tariff Hopes, Investor Fear Eases: Greed Index Remains In 'Fear' Zone
April 24, 2025
Via
Benzinga
Topics
Stocks
Stay informed with the top movers within the S&P500 index on Wednesday.
April 23, 2025
Stay informed about the performance of the S&P500 index one hour before the close of the markets on Wednesday. Uncover the top gainers and losers in today's session for valuable insights.
Via
Chartmill
Explore the top gainers and losers within the S&P500 index in today's session.
April 23, 2025
Curious about the top performers within the S&P500 index in the middle of the day on Wednesday? Dive into the list of today's session's top gainers and losers for a comprehensive overview.
Via
Chartmill
What's going on in today's pre-market session: S&P500 movers
April 23, 2025
Discover the top S&P500 movers in Wednesday's pre-market session and stay informed about market dynamics.
Via
Chartmill
Tesla To $303? Here Are 10 Top Analyst Forecasts For Wednesday
April 23, 2025
Via
Benzinga
Bristol Myers' Cobenfy Falls Short On Primary Endpoint In Phase 3 Schizophrenia Trial, Stock Slides
April 23, 2025
Bristol Myers' Cobenfy missed its primary endpoint in the Phase 3 ARISE trial but showed symptom improvement in certain subgroups.
Via
Benzinga
Bristol-Myers Squibb (BMY) Reports Earnings Tomorrow: What To Expect
April 23, 2025
Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be announcing earnings results tomorrow morning. Here’s what investors should know.
Via
StockStory
< Previous
1
2
3
4
5
6
7
8
9
...
75
76
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.